• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

AstraZeneca CEO's 2024 pay proposal under fire from influential proxy advisers

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 01, 2024 at 11:32: PM
via Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again.

Two influential advisory firms, Institutional Shareholder Services and Glass Lewis, are rallying investors to vote against AZ’s 2024 pay proposal for Soriot at the company’s annual general meeting later this month.

article source
 




Top Bottom
Back
Quote